Navigation Links
BMP Sunstone Reports Fourth Quarter and Full Year 2008 Financial Results
Date:3/17/2009

PLYMOUTH MEETING, Pa., March 17 /PRNewswire-Asia-FirstCall/ -- BMP Sunstone Corporation (Nasdaq: BJGP) ("BMP Sunstone" or the "Company"), today announced financial results for the fourth quarter and fiscal year ended December 31, 2008.

    Financial Highlights as of December 31, 2008:
    -- Fourth quarter revenues increased to $36.6 million, from $9.2 million
       in the fourth quarter of 2007.
    -- Non-GAAP operating income, as defined below, was $3.5 million for the
       quarter, improving from a loss of $4.7 million in the prior year period.
       Non-GAAP operating income for the twelve-month period was $10.5 million.
    -- Non-GAAP net income, as defined below, was $3.8 million for the quarter.
       Non-GAAP net income was $7.2 million for the twelve-month period.
    -- Non-GAAP EPS, as defined below, was $0.09 for the quarter and $0.19 for
       the twelve-month period.
    -- EBITDA was $10.6 million for the full year 2008.

Non-GAAP operating income, net income, and earnings per share exclude stock based compensation expense, amortization related to acquisitions, and amortization of debt discount and issuance cost. EBITDA is a non-GAAP measure which provides earnings before interest, taxes, depreciation and amortization. Please refer to the financial reconciliations provided in this news release for a reconciliation of GAAP results to non-GAAP results for the three and twelve month periods ended December 31, 2008 and 2007.

David Gao, Chief Executive Officer of BMP Sunstone, stated, "We are very proud of the progress we have made over the course of the last year, especially in light of the economic environment. We generated $3.3 million of operating cash flow through the year and the Sunstone acquisition greatly improved our top line and gross margin performance, while reven
'/>"/>

SOURCE BMP Sunstone Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. BMP Sunstone to Present at UBS Global Healthcare Services Conference
2. BMP Sunstone Adopts Voluntary Executive Compensation Restrictions in 2008 and 2009
3. BMP Sunstone Receives High Tech Status
4. BMP Sunstone to Present at the 20th Annual Piper Jaffray Health Care Conference
5. BMP Sunstone Acquires Runchang Capsule and Related LFHC Technology
6. BMP Sunstone to Host Follow-Up 3Q08 Conference Call Due to Technical Difficulties Encountered on Tuesdays Call
7. BMP Sunstone Reports Third Quarter 2008 Financial Results
8. BMP Sunstone Announces Participation in November Investor Conferences
9. BMP Sunstone Announces Participation in September Investor Conference
10. BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC
11. BMP Sunstone Reports Second Quarter 2008 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...swire-USNewswire/ -- The Michael J. Fox Foundation...1.5 million in total awards to six research teams ...herapies for Parkinson,s disease. The funding was ...ery for Parkinson,s Disease program, made possibl...LN ), a neuroscience-based biotechnology company. ...
(Date:11/30/2009)...30 Biopharmaceutical company Kiadi...ave been enrolled in its,multinational registratio...ned to show reduction in transplant related mortal...tem cell transplantation with a mismatched,(haplo-... for an allogeneic,stem cell transplantation but w...
(Date:11/30/2009)... Novavax, Inc. (Nasdaq: ... in the Phase II clinical study of its trivalent s...VLP vaccine candidate in healthy adults 60 years o...ouble-blind, active-controlled study is comparing ... different doses (15 mcg and 60 mcg) of Novavax,s ...
(Date:11/30/2009)...RNewswire-FirstCall/ -- Cell Therapeutics, Inc. (C...s new class of platinum-based anti-tumor compounds...nti-tumor potency and activity compared to current...he ability to overcome cisplatin-resistance in can...aper titled "Novel Bis-platinum Complexes Endowed ...
Breaking Biology Technology:The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 3NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 4New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3
... CHICAGO Early this year, the ongoing saga of the...those of you who havent been following the news ov...ile bid by French pharmaceutical giant Sanofi-Syn... giant Aventis . , ,This would create a real maj...bined company would create the worlds third-larges...
... Madison, Wis. -- Pulling an all-nighter has never...sconsin-Madison Business School students who won...s Lang, Gail McGuire and Paul Pucci, all MBA stude...nture capitalists and a $100 cash prize. , ,The ne...ing, is designed to put students in the role of ve...
... Madison, Wis. -- Third Wave Technologies Inc , a...announced the release of its Invader 2D6 analysis ...with access to a broad range of pharmacogenetic as...panel is a pharmacogenetic testing solution that o...onfigure custom assay panels. The panel is being u...
Other Biology Technology:The Industry Impact of Two Big Pharmas Mating 2The Industry Impact of Two Big Pharmas Mating 3The Industry Impact of Two Big Pharmas Mating 4The Industry Impact of Two Big Pharmas Mating 5The Industry Impact of Two Big Pharmas Mating 6The Industry Impact of Two Big Pharmas Mating 7VC Contest Winners Learn from Experience 2Third Wave Releases Gene Test 2
(Date:11/26/2009)...hitehead researchers have developed a new type of ...c genes and proteins used by pathogens, according ...l cultures genes are present in two copies: one in...ene inactivation by mutation is therefore ineffici...nd copy usually remains active and takes over. , ...
(Date:11/26/2009)...ccus Aureus ) and other drug-resistant bacteria co...ototype devices have been developed to offer safe,... , Two prototype devices have been developed: on... hands and feet) in hospitals and public spaces wh... to shoot bacteria-killing agents into infested ch...
(Date:11/25/2009)...ach, may be used to boost resistance to, or slow, ...l of Medicine researchers report in a study publis...nce . , Parkinson,s disease is caused by a degen...rain known as the substantia nigra, which is respo...n of dopamine in late-stage Parkinson,s causes sym...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Hormone ghrelin can boost resistance to Parkinson's disease 2Whooping Cough Immunity Lasts 30 Years or More 60406 1Whooping Cough Immunity Lasts 30 Years or More 60406 2Scientist Throws Curve Into Breaking Ball Debate 60403 1Scientist Throws Curve Into Breaking Ball Debate 60403 2Scientist Throws Curve Into Breaking Ball Debate 60403 3Anesiva Announces Date for 2009 Annual Meeting of Stockholders to Vote on Proposed Merger 60400 1Anesiva Announces Date for 2009 Annual Meeting of Stockholders to Vote on Proposed Merger 60400 2Anesiva Announces Date for 2009 Annual Meeting of Stockholders to Vote on Proposed Merger 60400 3
...der, CO, USA - BULLETIN papers examine carbon-14...ests high ice-sheet sensitivity to small climate c...ied fossil forest in the Gold Hill Loess, Alaska; ... shrimp affect groundwater flow in the Biscayne aq... Appalachian Basin; and banded iron formations exp...
...rn microscopy technology has allowed two scorpion ...ity in Berlin and Lorenzo Prendini of the American...what is nearly invisible. Looking at tiny morpholo... outgrowths on lamellaestructures that fold like t...ory system its name, the book lungKamenz and Prend...
...SON, WI, JANUARY 12, 2009 - With recent increase i...nto alternative energy sources, the increased harv...ion is likely in the future. This may be especiall... in part because perennially high residue amounts ...ue left on the soil surface is a source of inoculu...
Other Biology News:January-February GSA Bulletin media highlights 2January-February GSA Bulletin media highlights 3January-February GSA Bulletin media highlights 4January-February GSA Bulletin media highlights 5January-February GSA Bulletin media highlights 6January-February GSA Bulletin media highlights 7January-February GSA Bulletin media highlights 8January-February GSA Bulletin media highlights 9January-February GSA Bulletin media highlights 10January-February GSA Bulletin media highlights 11Microscopic morphology adds to the scorpion family tree 2Microscopic morphology adds to the scorpion family tree 3Preventing soil erosion in continuous corn 2
Pyrex brand Fernback baffled culture flask from Sigma-Aldrich
... simple and efficient means for isolation of apopt...netic beads (MagBeads). Annexin V is a Ca2+-depend...y for phosphatidylseri The Apoptotic Cell Isolati...solation of apoptotic cells or removal of dead cel...
Xylene Cyanole FF from Sigma-Aldrich
...igned to be a solid, heavy-duty durable orbital sh...ng and vortexing in nature. The VSOS-4 Orbital ...uniform orbital shaking motion (19mm circular) for...ell/tissue culture, hybridization, staining and de...
Biology Products: